Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist ...

Eli Lilly will invest more than $1.2bn into its manufacturing site in Puerto Rico, as the drugmaker looks to assemble a ...

The expansion of Lilly del Caribe facility in Carolina, Puerto Rico will add 100 new jobs.

Eli Lilly's $1.2 billion investment in Puerto Rico aims to enhance manufacturing capabilities and integrate advanced technologies for oral solid medicines. The investment is part of Lilly's broader ...

The investment, which will expand Eli Lilly’s existing campus in Puerto Rico, is slated to create 100 new jobs, on top of ...

The Carolina campus modernization will create 1,100 jobs boost production capacity, and strengthen the island’s role in U.S.

Eli Lilly invests $3B in a Netherlands plant to produce obesity drug orforglipron, creating new jobs. Read more here.

The expansion forms part of Lilly’s broader $50bn capital investment programme to grow its US manufacturing and production ...

Lilly said the plant will strengthen its global supply chain and expand the capacity for its growing portfolio of oral ...

Eli Lilly and Company has announced plans to invest more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Puerto Rico.

Along with the company’s investment plans in Puerto Rico, Lilly also announced plans to build a $5 billon manufacturing plant in Goochland County, Virgina, a $1 billion investment in its India-based ...

Mounjaro generated sales of $6.5bn in Q3 2025, up 109% from the same period in 2024. Zepbound exhibited even higher growth – ...